ClearPoint Neuro Inc (NASDAQ:CLPT) shares, rose in value on Friday, July 11, with the stock price down by -4.68% to the previous day’s close as strong demand from buyers drove the stock to $11.4.
Actively observing the price movement in the last trading, the stock closed the session at $11.96, falling within a range of $11.13 and $11.85. The value of beta (5-year monthly) was 0.94. Referring to stock’s 52-week performance, its high was $19.22, and the low was $6.25. On the whole, CLPT has fluctuated by -14.22% over the past month.
With the market capitalization of ClearPoint Neuro Inc currently standing at about $322.22 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-13.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CLPT’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of CLPT currently trading nearly -2.07% and -8.75% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 43.30, while the 7-day volatility ratio is showing 5.62% which for the 30-day chart, stands at 5.33%. Furthermore, ClearPoint Neuro Inc (CLPT)’s beta value is 0.86.
A comparison of ClearPoint Neuro Inc (CLPT) with its peers suggests the former has fared considerably weaker in the market. CLPT showed an intraday change of -4.68% in last session, and over the past year, it shrunk by -25.88%%.
Data on historical trading for ClearPoint Neuro Inc (NASDAQ:CLPT) indicates that the trading volumes over the past 10 days have averaged 0.77 and over the past 3 months, they’ve averaged 360.29K. According to company’s latest data on outstanding shares, there are 27.98 million shares outstanding.
Nearly 14.24% of ClearPoint Neuro Inc’s shares belong to company insiders and institutional investors own 29.40% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.19 million shares as on 2025-06-13, resulting in a short ratio of 3.68. According to the data, the short interest in ClearPoint Neuro Inc (CLPT) stood at 437.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 1.21 million. The stock has risen by 73.25% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CLPT stock heading into the next quarter.
